Denali Therapeutics Inc.

NASDAQ: DNLI · Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
15.73
6.97%
After-hours: Aug 15, 2025, 06:45 PM EDT

Denali Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-422.77M -145.22M -325.99M -290.58M
Depreciation & Amortization
8.99M 16.73M 10.38M 8.59M
Stock-Based Compensation
102.88M 108.1M 99.85M 85.25M
Other Working Capital
15.5M -292.36M -26.3M -24.12M
Other Non-Cash Items
-53.73M -47.67M -4.92M -2.98M
Deferred Income Tax
n/a n/a n/a 8.75M
Change in Working Capital
16.94M -289.93M -24.03M -20.41M
Operating Cash Flow
-347.69M -357.99M -244.72M -211.39M
Capital Expenditures
-15.91M -12.94M -17.83M -8.5M
Cash Acquisitions
n/a n/a 123.55M 13.13M
Purchase of Investments
-1.23B -1.81B -1.12B -1.42B
Sales Maturities Of Investments
1.16B 2.08B 991.49M 1.41B
Other Investing Acitivies
n/a n/a -123.55M -13.13M
Investing Cash Flow
-88.76M 249.31M -141.39M -21.63M
Debt Repayment
-32.34M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
17.39M 17.82M 14.46M 19.35M
Financial Cash Flow
484.3M 17.82M 310.67M 19.35M
Net Cash Flow
47.85M -90.86M -75.43M -213.67M
Free Cash Flow
-363.61M -370.93M -262.55M -219.89M